Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$5.85 USD
+0.44 (8.13%)
Updated Sep 22, 2025 03:59 PM ET
After-Market: $5.86 +0.01 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Karyopharm Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
KPTI 5.85 +0.44(8.13%)
Will KPTI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KPTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KPTI
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates
KPTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
United Therapeutics (UTHR) Misses Q2 Earnings Estimates
Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Here's Why Karyopharm Therapeutics (KPTI) Is a Great 'Buy the Bottom' Stock Now
Other News for KPTI
New Downtrend appears for KPTI after 5.58% move
Is KPTI gaining bullish strength? Non-ADX 1,2,3,4 Bullish shows up after tumbling 5.76%
KPTI's price falls by 2.88% on September 17, though its technical setup remains stable.
KPTI forms NR7 on September 16
KPTI forms 20 Day Moving Average Resistance on September 15